| |
| |
|
| Insider
Information: |
Sundheim Daniel S. |
| Relationship: |
Director, 10% Owner |
| City: |
Greenwich |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
11 |
|
| Direct
Shares |
6,706,798 |
|
|
Indirect Shares
|
219,878,002 |
|
|
| Direct
Value |
$222,686,831 |
|
|
|
Indirect Value
|
$3,416,663,119 |
|
|
| Total
Shares |
226,584,800 |
|
|
| Total
Value |
$3,639,349,950 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
12
|
6
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
11
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-6.0
|
| Percentage
Gain/Loss : |
 -64.5%
|
-407.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Wayfair Inc. |
W |
10% Owner |
2014-11-20 |
538,711 |
2014-11-20 |
1,791,536 |
Premium* |
|
|
Editas Medicine, Inc. |
EDIT |
Former 10% Owner |
2015-02-08 |
266,782 |
2015-02-08 |
2,729,808 |
Premium* |
|
|
First Data Corp |
FDC |
10% Owner |
2016-04-13 |
5,874,105 |
2016-04-13 |
21,750,064 |
Premium* |
|
|
Sio Gene Therapies Inc |
SIOX |
10% Owner |
|
0 |
2016-07-08 |
75,000,000 |
Premium* |
|
|
Tekmira Pharmaceuticals Corp |
TKMR |
10% Owner |
|
0 |
2016-07-08 |
16,013,540 |
Premium* |
|
|
Myovant Sciences Ltd. |
MYOV |
10% Owner |
|
0 |
2016-10-26 |
37,231,342 |
Premium* |
|
|
Outset Medical, Inc. |
OM |
10% Owner |
|
0 |
2020-09-17 |
4,575,754 |
Premium* |
|
|
Sight Sciences, Inc. |
SGHT |
10% Owner |
2021-07-19 |
0 |
2023-12-27 |
3,000,000 |
Premium* |
|
|
Finance Of America Companies Inc. |
FOA |
10% Owner |
2021-04-01 |
0 |
2021-12-15 |
5,000,000 |
Premium* |
|
|
Warby Parker Inc. |
WRBY |
10% Owner |
2022-02-18 |
27,200 |
2022-02-18 |
14,944,023 |
Premium* |
|
|
Maplebear Inc. |
CART |
Director, 10% Owner |
|
0 |
2023-09-21 |
37,841,935 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
47 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EDIT |
Editas Medicine, Inc. |
10% Owner |
– – • |
2015-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,709,401 |
1,709,401 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
10% Owner |
– – • |
2015-02-08 |
4 |
A |
$0.00 |
$0 |
I/I |
1,709,401 |
1,709,401 |
0 |
- |
|
| FDC |
First Data Corp |
10% Owner |
– – • |
2016-04-13 |
4 |
A |
$0.00 |
$0 |
D/D |
21,750,064 |
5,874,105 |
0 |
- |
|
| FDC |
First Data Corp |
10% Owner |
– – • |
2016-04-13 |
4 |
A |
$0.00 |
$0 |
I/I |
21,750,064 |
21,750,064 |
0 |
- |
|
| SGHT |
Sight Sciences, Inc. |
10% Owner |
– – • |
2021-07-19 |
4 |
A |
$0.00 |
$0 |
I/I |
5,152,036 |
5,152,036 |
0 |
- |
|
| CART |
Maplebear Inc. |
Director |
– • • |
2023-09-21 |
4 |
A |
$0.00 |
$0 |
I/I |
34,812,711 |
36,741,188 |
0 |
- |
|
| CART |
Maplebear Inc. |
Director |
– • • |
2023-09-21 |
4 |
A |
$0.00 |
$0 |
I/I |
115,030 |
14,283 |
0 |
- |
|
| W |
Wayfair Inc. |
10% Owner |
– – • |
2014-10-02 |
4 |
B |
$0.00 |
$0 |
D/D |
373,789 |
497,411 |
2.37 |
- |
|
| W |
Wayfair Inc. |
10% Owner |
– – • |
2014-10-02 |
4 |
B |
$0.00 |
$0 |
I/I |
479,250 |
1,750,236 |
1.42 |
- |
|
| W |
Wayfair Inc. |
10% Owner |
– – • |
2014-11-03 |
4 |
B |
$25.17 |
$30,205 |
D/D |
1,200 |
498,611 |
2.37 |
- |
|
| W |
Wayfair Inc. |
10% Owner |
– – • |
2014-11-03 |
4 |
B |
$25.17 |
$30,205 |
I/I |
1,200 |
1,751,436 |
1.5 |
- |
|
| W |
Wayfair Inc. |
10% Owner |
– – • |
2014-11-07 |
4 |
B |
$0.00 |
$0 |
D/D |
22,500 |
521,111 |
2.37 |
- |
|
| W |
Wayfair Inc. |
10% Owner |
– – • |
2014-11-07 |
4 |
B |
$0.00 |
$0 |
I/I |
22,500 |
1,773,936 |
1.42 |
- |
|
| W |
Wayfair Inc. |
10% Owner |
– – • |
2014-11-20 |
4 |
B |
$22.73 |
$400,034 |
D/D |
17,600 |
538,711 |
2.45 |
- |
|
| W |
Wayfair Inc. |
10% Owner |
– – • |
2014-11-20 |
4 |
B |
$22.73 |
$400,034 |
I/I |
17,600 |
1,791,536 |
1.5 |
- |
|
| EDIT |
Editas Medicine, Inc. |
10% Owner |
– – • |
2015-02-08 |
4 |
B |
$0.00 |
$0 |
D/D |
1,020,407 |
266,782 |
2.37 |
- |
|
| EDIT |
Editas Medicine, Inc. |
10% Owner |
– – • |
2015-02-08 |
4 |
B |
$0.00 |
$0 |
I/I |
1,020,407 |
2,729,808 |
1.42 |
- |
|
| SGHT |
Sight Sciences, Inc. |
10% Owner |
– – • |
2021-07-19 |
4 |
B |
$24.00 |
$16,800,000 |
I/I |
700,000 |
5,852,036 |
1.5 |
- |
|
| WRBY |
Warby Parker Inc. |
10% Owner |
– – • |
2021-10-11 |
4 |
B |
$49.55 |
$33,152,220 |
I/I |
669,066 |
10,872,148 |
1.5 |
% |
|
| WRBY |
Warby Parker Inc. |
10% Owner |
– – • |
2021-10-11 |
4 |
B |
$50.96 |
$6,179,980 |
I/I |
120,934 |
10,993,082 |
1.5 |
% |
|
| WRBY |
Warby Parker Inc. |
10% Owner |
– – • |
2021-10-12 |
4 |
B |
$51.26 |
$18,130,252 |
I/I |
353,692 |
11,346,774 |
1.5 |
% |
|
| WRBY |
Warby Parker Inc. |
10% Owner |
– – • |
2021-10-13 |
4 |
B |
$52.47 |
$7,998,894 |
I/I |
152,447 |
11,499,221 |
1.5 |
% |
|
| WRBY |
Warby Parker Inc. |
10% Owner |
– – • |
2021-10-14 |
4 |
B |
$53.02 |
$11,657,083 |
I/I |
219,862 |
11,719,083 |
1.5 |
% |
|
| WRBY |
Warby Parker Inc. |
10% Owner |
– – • |
2021-10-14 |
4 |
B |
$53.42 |
$9,295,027 |
I/I |
173,999 |
11,893,082 |
1.5 |
% |
|
| WRBY |
Warby Parker Inc. |
10% Owner |
– – • |
2021-10-15 |
4 |
B |
$54.44 |
$9,548,465 |
I/I |
175,000 |
12,068,082 |
1.5 |
% |
|
47 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
